tirzepatide approved by fda vs. Semaglutide: What You Should Know FDA approves weight-loss drug Zepbound

Muntoni S, Wiebusch H, Jansen-Rust M, Rust S, Seedorf U, Schulte H, Berger K, Funke H, Assmann G

GLP-1 Plus , B2 GLP

Because of the unknown potential for serious adverse reactions in the breastfed infant due to the possible accumulation of SNAC, an absorption enhancer for Wegovy tablets, and because there are alternative formulations of semaglutide that do not contain SNAC that can be used during lactation, advise patients that breastfeeding is not recommended during treatment with Wegovy tablets

Given that the GM of RA patients differs from the general population and that anti-rheumatic drugs can exert positive effects on its regulation (Manasson et al., 2020)